more_reports

ACADIA Pharmaceuticals Inc.

ACAD:NASDAQ

ACADIA is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders. ACADIA has developed and commercialized the first and only medicine approved for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. ACADIA also has ongoing clinical development efforts in additional areas with significant unmet need, including dementia-related psychosis, major depressive disorder, the negative symptoms of schizophrenia, and Rett syndrome.

streetwise book logo Streetwise Company Fact Sheet

2024/7/17 16:33:18

(ACAD:NASDAQ)